Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$13,634
New position
Shares Held
87
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,520
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOUNJIAN ADVISORY PARTNERS, LLC holds $1,012,993 across 12 Drug Manufacturers - General names. NVS ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,674 | $679,115 | |
| 2 | ABBV |
AbbVie Inc.
|
657 | $165,327 | |
| 3 | LLY |
ELI LILLY & Co
|
58 | $69,566 | |
| 4 | MRK |
Merck & Co., Inc.
|
305 | $39,192 | |
| 5 | PFE |
Pfizer Inc
|
776 | $18,686 | |
| 6 | NVS |
Novartis AG
This page
|
87 | $13,634 | |
| 7 | AMGN |
Amgen Inc
|
35 | $12,674 | |
| 8 | GSK |
GSK plc
|
104 | $5,451 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,634 | 87 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||